12305 related articles for article (PubMed ID: 11592301)
1. Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro.
Brooks TD; Slomp J; Quax PH; De Bart AC; Spencer MT; Verheijen JH; Charlton PA
Clin Exp Metastasis; 2000; 18(6):445-53. PubMed ID: 11592301
[TBL] [Abstract][Full Text] [Related]
2. Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation.
Brandal S; Blake CM; Sullenger BA; Fortenberry YM
Nucleic Acid Ther; 2011 Dec; 21(6):373-81. PubMed ID: 22103403
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice.
Geiger T; Müller M; Dean NM; Fabbro D
Anticancer Drug Des; 1998 Jan; 13(1):35-45. PubMed ID: 9474241
[TBL] [Abstract][Full Text] [Related]
4. [The leopard syndrome, a cardio-cutaneous syndrome].
Jurecka W; Gebhart W; Knobler R; Schmoliner R; Möslacher H
Wien Klin Wochenschr; 1983 Sep; 95(18):652-6. PubMed ID: 6228069
[TBL] [Abstract][Full Text] [Related]
5. High-dose adjuvant interferon therapy for melanoma.
Licata AG
Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
[TBL] [Abstract][Full Text] [Related]
6. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
[TBL] [Abstract][Full Text] [Related]
7. Organ culture of mammalian skin and the effects of ultraviolet light and testosterone on melanocyte morphology and function.
Glimcher ME; Garcia RI; Szabó G
J Exp Zool; 1978 May; 204(2):229-37. PubMed ID: 641488
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma.
Yang TH; Aosai F; Norose K; Ueda M; Yano A
Microbiol Immunol; 1996; 40(6):443-9. PubMed ID: 8839430
[TBL] [Abstract][Full Text] [Related]
9. Perinodular injection of thymopentin (TP5) in cutaneous and subcutaneous metastases of melanoma.
Cascinelli N; Clemente C; Bufalino R; Baldini M; Mascheroni L; Zurrida S; Mihm MC
Melanoma Res; 1993 Dec; 3(6):471-6. PubMed ID: 8161886
[TBL] [Abstract][Full Text] [Related]
10. Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters.
Tveit KM; Fodstad O; Lotsberg J; Vaage S; Pihl A
Int J Cancer; 1982 May; 29(5):533-8. PubMed ID: 7095899
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use and malignant melanoma.
Bain C; Hennekens CH; Speizer FE; Rosner B; Willett W; Belanger C
J Natl Cancer Inst; 1982 Apr; 68(4):537-9. PubMed ID: 6951070
[TBL] [Abstract][Full Text] [Related]
12. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma.
Koprowski H; Herlyn M; Balaban G; Parmiter A; Ross A; Nowell P
Somat Cell Mol Genet; 1985 May; 11(3):297-302. PubMed ID: 2988138
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinoic acid on tumor-mediated immunologic alterations in mice bearing a variant of the B16 melanoma.
Jiang CG; Taylor DD; Black PH
Int J Cancer; 1990 Dec; 46(6):1054-8. PubMed ID: 2249892
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of trehalose-loaded liposomes against UVB-induced photodamage in human keratinocytes.
Emanuele E; Bertona M; Sanchis-Gomar F; Pareja-Galeano H; Lucia A
Biomed Rep; 2014 Sep; 2(5):755-759. PubMed ID: 25054023
[TBL] [Abstract][Full Text] [Related]
15. Giant congenital nevocellular nevus overlying an encephalocele.
Shermak MA; Perlman EJ; Carson BS; Dufresne CR
J Craniofac Surg; 1996 Sep; 7(5):376-83. PubMed ID: 9133851
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
17. Subungual melanoma: an eighteen-year review.
Finley RK; Driscoll DL; Blumenson LE; Karakousis CP
Surgery; 1994 Jul; 116(1):96-100. PubMed ID: 8023276
[TBL] [Abstract][Full Text] [Related]
18. Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.
Chen WT; Lee CC; Goldstein L; Bernier S; Liu CH; Lin CY; Yeh Y; Monsky WL; Kelly T; Dai M
Breast Cancer Res Treat; 1994; 31(2-3):217-26. PubMed ID: 7881100
[TBL] [Abstract][Full Text] [Related]
19. Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.
Nicolson GL; Fidler IJ; Poste G
J Natl Cancer Inst; 1986 Mar; 76(3):511-9. PubMed ID: 3456465
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
